(Q59070397)

27

Gordon Mills

0 references

Giorgos Karakousis

33

Rajasekharan Somasundaram

Giorgos C Karakousis

0 references

25

Rajasekharan Somasundaram

0 references

Wenqun Zhong

13

Wenqun Zhong

0 references

E. John Wherry

37

E John Wherry

0 references

author name string

Gang Chen

1

0 references

Alexander C Huang

2

0 references

Wei Zhang

3

0 references

Gao Zhang

4

0 references

Min Wu

5

0 references

Wei Xu

6

0 references

Zili Yu

7

0 references

Jiegang Yang

8

0 references

Beike Wang

9

0 references

Honghong Sun

10

0 references

Houfu Xia

11

0 references

Qiwen Man

12

0 references

Leonardo F Antelo

14

0 references

Bin Wu

15

0 references

Xuepeng Xiong

16

0 references

Xiaoming Liu

17

0 references

Lei Guan

18

0 references

Ting Li

19

0 references

Shujing Liu

20

0 references

Ruifeng Yang

21

0 references

Youtao Lu

22

0 references

Liyun Dong

23

0 references

Suzanne McGettigan

24

0 references

Ravi Radhakrishnan

26

0 references

Yiling Lu

28

0 references

Junhyong Kim

29

0 references

Youhai H Chen

30

0 references

Haidong Dong

31

0 references

Yifang Zhao

32

0 references

Tara C Mitchell

34

0 references

Lynn M Schuchter

35

0 references

Xiaowei Xu

38

0 references

Wei Guo

Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.

39

0 references

language of work or name

English

0 references

publication date

August 2018

0 references

published in

Nature

0 references

volume

560

0 references

issue

7718

0 references

page(s)

382-386

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Clinical significance of PD-L1+ exosomes in plasma of Head and Neck Cancer patients

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

The biology and function of exosomes in cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

PD-1 blockade induces responses by inhibiting adaptive immune resistance

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Regulation of immune responses by extracellular vesicles

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Rab27a and Rab27b control different steps of the exosome secretion pathway

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Isolation and characterization of exosomes from cell culture supernatants and biological fluids

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740

T cell receptor antagonist peptides induce positive selection

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6095740